We further examined the impact of d16HER2 expression on the stemness of HER2+ BC cells in patients, and found that BC patients with high expression levels of the activated-d16HER2 metagene exhibited significant enrichment of the Notch family and signal transducer genes, compared with those with low expression of the metagene [37]. The gene discussed is ERBB2; the disease is breast cancer.